Literature DB >> 12195000

Non-alcoholic steatohepatitis: a common cause of progressive chronic liver injury?

C D J Evans1, K A Oien, R N M MacSween, P R Mills.   

Abstract

AIM: To investigate the natural history of patients with non-alcoholic steatohepatitis by means of a prospective histological study.
METHODS: One thousand five hundred and seventy one patients underwent liver biopsy at the Western Infirmary in Glasgow during the 10 year period 1985 to 1994. All biopsies were reported by a single pathologist: 62 were confirmed as having non-alcoholic steatohepatitis and prospective follow up was conducted in 1999. Repeat liver biopsy was carried out where appropriate to assess disease progression.
RESULTS: Initial biopsy scores for the 62 patients (20 men; mean age at biopsy, 52 years) showed a mean of 1.85, 1.39, and 0.5 for necroinflammation, fibrosis, and iron stores, respectively. Forty six were traceable and invited for review, and 26 attended (six men; mean age at initial biopsy, 49.9 years) at a mean of 8.7 years after the initial liver biopsy. No patients had symptoms or signs of chronic liver disease. Four patients had normal liver function tests, one had cirrhosis; the remaining 21 were invited to have a repeat biopsy. Seven patients agreed, a mean 8.2 years after the initial biopsy, and repeat biopsy scores showed no significant difference over this time period, with mean scores of 1.71 (initial score, 2.14), 1.43 (initial score, 0.71), and 0.14 (initial score, 0) for necroinflammation, fibrosis, and iron stores, respectively.
CONCLUSION: In this series of patients with non-alcoholic steatohepatitis, with a mean clinical follow up of 8.7 years, and a histological follow up of 8.2 years, there was no evidence of progressive chronic liver injury.

Entities:  

Mesh:

Year:  2002        PMID: 12195000      PMCID: PMC1769755          DOI: 10.1136/jcp.55.9.689

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  34 in total

1.  Cirrhosis with steatohepatitis after adjuvant tamoxifen.

Authors:  K A Oien; D Moffat; G W Curry; J Dickson; T Habeshaw; P R Mills; R N MacSween
Journal:  Lancet       Date:  1999-01-02       Impact factor: 79.321

Review 2.  Non-alcoholic steatohepatitis (NASH): a disease of emerging identity and importance.

Authors:  O F James; C P Day
Journal:  J Hepatol       Date:  1998-09       Impact factor: 25.083

3.  A high prevalence of HLA-H 845A mutations in hemochromatosis patients and the normal population in eastern England.

Authors:  G Willis; B A Jennings; E Goodman; I W Fellows; J Z Wimperis
Journal:  Blood Cells Mol Dis       Date:  1997-08       Impact factor: 3.039

4.  Steatohepatitis: a tale of two "hits"?

Authors:  C P Day; O F James
Journal:  Gastroenterology       Date:  1998-04       Impact factor: 22.682

5.  Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler.

Authors:  R G Lee
Journal:  Hepatology       Date:  1995-06       Impact factor: 17.425

6.  Increased hepatic iron concentration in nonalcoholic steatohepatitis is associated with increased fibrosis.

Authors:  D K George; S Goldwurm; G A MacDonald; L L Cowley; N I Walker; P J Ward; E C Jazwinska; L W Powell
Journal:  Gastroenterology       Date:  1998-02       Impact factor: 22.682

7.  Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups.

Authors:  T Poynard; P Bedossa; P Opolon
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

Review 8.  Nonalcoholic steatohepatitis.

Authors:  B A Neuschwander-Tetri; B R Bacon
Journal:  Med Clin North Am       Date:  1996-09       Impact factor: 5.456

9.  Clinical hepatology: profile of an urban, hospital-based practice.

Authors:  D Byron; G Y Minuk
Journal:  Hepatology       Date:  1996-10       Impact factor: 17.425

10.  Nonalcoholic steatohepatitis: an expanded clinical entity.

Authors:  B R Bacon; M J Farahvash; C G Janney; B A Neuschwander-Tetri
Journal:  Gastroenterology       Date:  1994-10       Impact factor: 22.682

View more
  26 in total

1.  Identification of nonalcoholic fatty liver disease following pancreatectomy for noninvasive intraductal papillary mucinous neoplasm.

Authors:  Carrie Luu; Ram Thapa; Trevor Rose; Katherine Woo; Daniel Jeong; Kerry Thomas; Dung-Tsa Chen; Mark Friedman; Mokenge P Malafa; Pamela J Hodul
Journal:  Int J Surg       Date:  2018-09-12       Impact factor: 6.071

Review 2.  Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

Authors:  Siddharth Singh; Alina M Allen; Zhen Wang; Larry J Prokop; Mohammad H Murad; Rohit Loomba
Journal:  Clin Gastroenterol Hepatol       Date:  2014-04-24       Impact factor: 11.382

3.  The spontaneous course of liver enzymes and its correlation in nonalcoholic fatty liver disease.

Authors:  Phunchai Charatcharoenwitthaya; Keith D Lindor; Paul Angulo
Journal:  Dig Dis Sci       Date:  2012-02-29       Impact factor: 3.199

4.  Hepatic steatosis is associated with an increased risk of carotid atherosclerosis.

Authors:  Henry Volzke; Daniel-M Robinson; Volker Kleine; Roland Deutscher; Wolfgang Hoffmann; Jan Ludemann; Ulf Schminke; Christof Kessler; Ulrich John
Journal:  World J Gastroenterol       Date:  2005-03-28       Impact factor: 5.742

5.  Nonalcoholic Fatty Liver Disease: Clinical Features and Pathogenesis.

Authors:  Metin Basaranoglu; Brent A Neuschwander-Tetri
Journal:  Gastroenterol Hepatol (N Y)       Date:  2006-04

Review 6.  Nonalcoholic fatty liver disease: current issues and novel treatment approaches.

Authors:  Romina Lomonaco; Nishanth E Sunny; Fernando Bril; Kenneth Cusi
Journal:  Drugs       Date:  2013-01       Impact factor: 9.546

Review 7.  Histology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis in Adults and Children.

Authors:  David E Kleiner; Hala R Makhlouf
Journal:  Clin Liver Dis       Date:  2015-12-28       Impact factor: 6.126

Review 8.  Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.

Authors:  Vikas Khullar; Angela Dolganiuc; Roberto J Firpi
Journal:  World J Transplant       Date:  2014-06-24

Review 9.  Pathogenesis and management issues for non-alcoholic fatty liver disease.

Authors:  Marko Duvnjak; Ivan Lerotić; Neven Barsić; Vedran Tomasić; Lucija Virović Jukić; Vedran Velagić
Journal:  World J Gastroenterol       Date:  2007-09-14       Impact factor: 5.742

10.  MR Elastography of Liver Disease: State of the Art.

Authors:  Jun Chen; Meng Yin; Kevin J Glaser; Jayant A Talwalkar; Richard L Ehman
Journal:  Appl Radiol       Date:  2013-04
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.